Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of malignancy on clinical outcomes in patients with acute coronary syndromes.
Yousif N, Niederseer D, Davies A, El Issa M, Sidia B, Noor HA, Amin H, Räber L, Gencer B, Klingenberg R, Windecker S, Mach F, Matter CM, Nanchen D, Lüscher TF, Obeid S. Yousif N, et al. Among authors: raber l. Int J Cardiol. 2021 Apr 1;328:8-13. doi: 10.1016/j.ijcard.2020.12.010. Epub 2020 Dec 13. Int J Cardiol. 2021. PMID: 33321124
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, Togni M, Billinger M, Tüller D, Seiler C, Roffi M, Corti R, Sütsch G, Maier W, Lüscher T, Hess OM, Egger M, Meier B. Windecker S, et al. Among authors: raber l. N Engl J Med. 2005 Aug 18;353(7):653-62. doi: 10.1056/NEJMoa051175. Epub 2005 Aug 16. N Engl J Med. 2005. PMID: 16105989 Free article. Clinical Trial.
Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy.
Wykrzykowska JJ, Räber L, de Vries T, Bressers M, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Regar E, Jüni P, Windecker S, Serruys PW. Wykrzykowska JJ, et al. Among authors: raber l. EuroIntervention. 2009 Aug;5(3):310-7. doi: 10.4244/v5i3a49. EuroIntervention. 2009. PMID: 19736154 Free article. Clinical Trial.
The DESIRE-Late registry: what is left to be desired?
Windecker S, Räber L. Windecker S, et al. Among authors: raber l. JACC Cardiovasc Interv. 2010 Jan;3(1):19-21. doi: 10.1016/j.jcin.2009.11.008. JACC Cardiovasc Interv. 2010. PMID: 20129563 Free article. No abstract available.
Current status of drug-eluting stents.
Räber L, Windecker S. Räber L, et al. Cardiovasc Ther. 2011 Jun;29(3):176-89. doi: 10.1111/j.1755-5922.2010.00144.x. Epub 2010 Mar 29. Cardiovasc Ther. 2011. PMID: 20370793 Free article. Review.
Sirolimus versus paclitaxel coronary stents in clinical practice.
Millauer N, Jüni P, Hofmann A, Wandel S, Bhambhani A, Billinger M, Urwyler N, Wenaweser P, Hellige G, Räber L, Cook S, Vogel R, Togni M, Seiler C, Meier B, Windecker S. Millauer N, et al. Among authors: raber l. Catheter Cardiovasc Interv. 2011 Jan 1;77(1):5-12. doi: 10.1002/ccd.22597. Catheter Cardiovasc Interv. 2011. PMID: 20506333
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study.
Eshtehardi P, Cook S, Wandel S, Räber L, Wenaweser P, Togni M, Vogel R, Garachemani A, Eberli FR, Lüscher TF, Jüni P, Hess OM, Meier B, Windecker S. Eshtehardi P, et al. Among authors: raber l. EuroIntervention. 2010 Sep;6(4):467-74. doi: 10.4244/EIJ30V6I4A79. EuroIntervention. 2010. PMID: 20884434 Free article.
428 results